Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rosuvastatin for immune activation in treatment-naive HIV-positive adults
NL-OMON35121Active, not recruiting
- Sponsor
- OLVG
- Start
- Apr 2011
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Randomised trial in human immunodeficiency virus infection (HIV) comparing Rosuvastatin with Placebo (2 arms). Primary endpoints: Circulating lipopolysaccharide, TLR mRNA expression in whole blood and 7 more. Started Apr 2011; status: active, not recruiting.
02
Drugs
rosuvastatin
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NL-OMON35121.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON35121.